Method of treating asthma using an IL-13 antibody
US11226341B2 · kind B2 · utility
4Cited by
103References
27Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | May 29, 2018 |
| Grant date | Jan 18, 2022 |
| Priority date | — |
| Expiry date | May 29, 2038 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01N2800/52
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Methods of diagnosing and treating disorders related to TH2 inhibition, including but not limited to asthma, are provided. Also provided are methods of selecting or identifying patients for treatment with certain therapeutic agents that are TH2 pathway inhibitors.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.